Table 1.
Origin, biofilm adherence classification, direct repeat unit (dru) and sequence type of study isolates
| Isolate selected | Adherence capabilities | Dru typing | Sequence type | Origin location |
|---|---|---|---|---|
| A3 |
LOW |
9a |
71 |
U.S.A |
| A12 |
STRONG |
10h |
68 |
U.S.A |
| A23 |
STRONG |
10a |
68 |
U.S.A |
| A46 |
MODERATE |
9a |
71 |
U.S.A |
| A56 |
LOW |
9a |
71 |
U.S.A |
| A92 |
MODERATE |
9a |
71 |
U.S.A |
| SP87 |
LOW |
9a |
71 |
Canada |
| SP88 |
LOW |
9a |
71 |
Canada |
| SP90 |
STRONG |
9a |
71 |
Canada |
| SP91 |
LOW |
9a |
71 |
Canada |
| SP93 |
LOW |
9a |
71 |
Canada |
| SP102 |
LOW |
11a |
68 |
Canada |
| SP104 |
MODERATE |
10h |
68 |
Canada |
| SP105 |
MODERATE |
10h |
68 |
Canada |
| SP106 |
MODERATE |
9a |
71 |
Canada |
| SP112 |
MODERATE |
9a |
71 |
Canada |
| SP113 |
MODERATE |
9a |
71 |
Canada |
| SP114 |
LOW |
9a |
71 |
Canada |
| SP115 |
LOW |
9a |
71 |
Canada |
| SP116 | LOW | 9a | 71 | Canada |
Dru typing of chosen biofilm forming isolates of MRSP reveals a representative population of strains commonly found in veterinary hospitals across North America. Adherence capabilities were determined based on the model developed by Stepanovic et al., 2000.